claim
Senomorphics, also known as SASP inhibitors, target pathways such as p38 MAPK, JAK/STAT, and interleukins to attenuate the senescence-associated secretory phenotype (SASP) of senescent cells.
Authors
Sources
- Cellular rejuvenation: molecular mechanisms and potential ... - Nature www.nature.com via serper
Referenced by nodes (2)
- senescent cells concept
- senescence-associated secretory phenotype concept